Explainer

Callus Culture Extracts Show Anti-Aging Activity in the Lab, But Human Data Lags Behind

A new review in the Journal of Cosmetic Dermatology finds callus-cultured plant extracts boost collagen and block elastase in lab tests, but admits human clinical proof is still scarce.

Published

Callus culture is a lab technique that grows undifferentiated plant tissue in a dish rather than harvesting it from a field, and a new review in the Journal of Cosmetic Dermatology argues it deserves attention as a source of anti-aging cosmetic ingredients. The authors, led by Amir Mohammad Sharafi and colleagues, surveyed callus cultures grown from apple (Malus domestica), rice (Oryza sativa), Centella asiatica, and Aster yomena, all species already familiar to skincare formulators in their whole-plant or extract forms.

The appeal of the method is production control. Because callus tissue grows in a controlled vessel rather than a farm plot, researchers can adjust plant hormone levels to push the cells toward making more of a desired compound class, sidestepping the batch-to-batch variation and contamination risk that come with field-sourced botanicals. The review frames this as a supply-chain argument as much as a biological one: consistent inputs make consistent extracts.

On mechanism, the review reports a consistent pattern across the plant species it covers. Callus-derived extracts increased keratinocyte proliferation, stimulated collagen synthesis, inhibited elastase activity, and lowered inflammatory markers in laboratory testing. Elastase inhibition and antioxidant capacity, measured with standard assays like DPPH, ABTS, and ORAC, are the two properties most directly tied to visible skin aging, since elastase breaks down the elastin fibers that keep skin resilient, and oxidative stress accelerates that breakdown.

The paper is explicit about where its evidence stops. Its own discussion section states that reported effects derive largely from acellular biochemical assays and cell-based studies in keratinocytes and fibroblasts, while controlled human clinical data remain limited to a small number of studies. That is a meaningful gap for any formulator or marketer reading the results: a compound that inhibits elastase in a test tube has not yet been shown to reduce wrinkles on a face.

The authors' own framing for that gap is that the geroprotective claims should be interpreted in light of this evidence hierarchy, and the conclusions are promising but preliminary pending larger clinical validation. That sentence draws a clear line between what callus culture technology can currently document, laboratory-confirmed biochemical activity, and what it cannot yet claim, proven human anti-aging outcomes, even as the underlying production technique itself continues to mature.

refulgo
Menu